CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Nuvamid's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
Apr 17, 2024Use Of Nmn For The Prevention And/Or Treatment Of Joint Pain Induced By Physical Activity, And Corresponding Compositions1
Jan 31, 2024Nicotinamide Mononucleotide Derivatives And Use Thereof In The Treatment And Prevention Of A Red Blood Cell Disorder1
Jan 24, 2024Use Of Nmn For The Prevention And/Or Treatment Of Pain, And Corresponding Compositions1

Top competitors of Nuvamid

List of top competitors of Nuvamid based on patent oppositions.